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Abstract
Wnt/β-catenin signaling is of significant interest due to the roles it plays in regulating 
development, tissue regeneration and disease. Transcriptional reporters have been widely 
employed to study Wnt/β-catenin signal transduction in live cells and whole organisms and have 
been applied to understanding embryonic development, exploring oncogenesis and developing 
therapeutics. Polyclonal heterogeneity in reporter cell lines has historically been seen as a 
challenge to be overcome in the development of novel cell lines and reporter-based assays, and 
monoclonal reporter cell lines are commonly employed to reduce this variability. A375 cell lines 
infected with a reporter for Wnt/β-catenin signaling were screened over short (< 6) and long (> 25) 
generational timescales. To characterize phenotypic divergence these time-scales, a 
microfabricated cell array-based screen was developed enabling characterization of 1,119 clonal 
colonies in parallel. This screen revealed phenotypic divergence after <6 generations at a similar 
scale to that observed in monoclonal cell lines cultured for >25 generations. Not only were 
reporter dynamics observed to diverge widely, but monoclonal cell lines were observed with 
seemingly opposite signaling phenotypes. Additionally, these observations revealed a 
generational-dependent trend in Wnt signaling in A375 cells that provide insight into the 
pathway’s mechanisms of positive feedback and self-inhibition.
Introduction
Wnt/β-catenin signaling is an evolutionarily conserved signaling pathway that is involved in 
development, adult tissue homeostasis, tissue regeneration, and disease. In the absence of 
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Wnt ligand signaling, β-catenin levels are kept low through ubiquitination and proteosome-
dependent degradation. Specifically, cytosolic β-catenin is captured by a complex of 
proteins comprising GSK3β, CK1a, APC and AXIN, which promote its phosphorylation and 
subsequent ubiquitination by the β-TrCP ubiquitin ligase. Binding of the Wnt ligand to the 
frizzled receptor inhibits GSK3b-dependent phosphorylation of b-catenin, leading to 
increased b-catenin levels and stability. β-catenin is then translocated to the nucleus and acts 
as a co-activator for TCF/LEF family transcription factors. Wnt signaling interacts with a 
large number of signaling pathways in normal and pathological contexts and large-scale 
screening efforts continue to identify many novel regulators and potential therapeutic 
targets.1–4 The importance of single-cell measurements in the study of tumor systems and 
signaling pathways has been highlighted by the observation of significant heterogeneity in 
Wnt signaling at the single-cell level in primary tumor-derived spheroid cultures5 as well as 
by mounting evidence for the role of genomic and phenotypic heterogeneity in the evolution 
and adaptation of tumors.6–9
Transcriptional reporters based on the production of chemiluminescence and fluorescence 
signals have been used successfully in the study of a wide variety of signaling 
pathways.10–13 Transcriptional reporters of Wnt/β-catenin signaling have been employed 
with great success leading to the discovery of several novel regulators of Wnt 
signaling.3,1,2,11 Since Wnt/β-catenin signaling culminates in the co-activation of TCF/LEF 
family members, transcriptional reporters of Wnt/β-catenin signaling typically contain 
multiple TCF/LEF binding sites upstream of a reporter gene. While transcriptional reporters 
measure Wnt pathway activation by virtue of the induced activity of downstream 
transcription factors, direct measurements of signaling activation are also possible by 
tracking the localization of β-catenin. Immunohistochemical methods permit observation of 
nuclear accumulation of β-catenin as a readout for Wnt pathway activation14, however the 
dynamic range and the strength of the signal can vary widely as Wnt signaling is highly 
sensitive to changes in nuclear β-catenin levels rather than the absolute amount present.15 
Additionally, staining can only be performed in fixed cells and significant amounts of β-
catenin will be present in adherens junctions at the cell membrane making measurement of 
nuclear concentrations challenging. Fusions of β-catenin and fluorescent proteins enable 
high-contrast, real-time tracking of signaling in live cells16; however, this strategy suffers 
from many of the same disadvantages of immunohistochemistry with respect to dynamic 
range and signal strength. In addition, there remains the risk that the fusion protein 
significantly alters the function and dynamics of protein degradation and translocation due 
to potential steric hindrance from the addition of the bulky fluorescent protein component. 
For these reasons, transcriptional reporters of Wnt/β-catenin signaling remains the most 
widely used method to measure pathway activation in living cells.
Modern techniques for the study of intracellular signaling depend on the availability of 
robust and rapid measures of intracellular signaling activity. The quantitative biomolecular 
and biophysical characterization of intracellular signaling is highly dependent on the 
dynamic range and intensity of the reporter signal. While luminescent reporters (through the 
use of firefly luciferase as the reporter gene17) remain the most sensitive readout for reporter 
activation, fluorescent protein-based reporters permit measurement of reporter activation in 
single, live cells.18 In an attempt to reduce cell-to-cell variability to permit more sensitive 
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measurements pooled over multiple cells, monoclonal cell lines are often employed for 
fluorescent reporters.19–23 Noise from polyclonal variability can also be reduced by 
averaging measurements over a larger number of cells but this leads to increased reagent 
consumption, reduced throughput and limited dynamic range. These dynamics and 
variability of fluorescent transcriptional reporters for β-catenin have not been well 
characterized in the literature, particularly in the context of the evolution of reporter 
performance in monoclonal cell lines.
This study presents a detailed characterization of a β-catenin activated reporter driving 
expression of a nuclear localization signal tagged red fluorescent protein (BAR-mCherry) in 
A375, a cell line derived from human melanoma24 that does not exhibit abnormal nuclear 
accumulation of β-catenin.25 The dynamics of BAR-mCherry activation and relaxation were 
measured in 6 monoclonal cell lines expanded from single isolated A375-BAR-mCherry 
cells. A parallel clonogenic assay was implemented using microfabricated cell arrays to 
characterize the emergence of heterogeneous reporter activation over time-scales 
significantly shorter than that required to expand single cells into monoclonal cell lines. A 
detailed study of the dynamics of transcriptional reporter activation in monoclonal 
populations would be of significant value in the design and optimization of assays utilizing 
similar reporter systems. Additionally, parallel clonogenic screening of reporter cell line 
colonies may shed light on the mechanisms by which reporter cell lines evolve and enable 
the generation of more stable and uniform reporter libraries.
Materials and Methods
Plasmids, Cell Culture and Transfection
A375 human melanoma cells were sourced from the American Type Culture Collection 
(ATCC). pSL9-BAR-NLS-mCherry was made by mutating pSL9-BAR-Luciferase using site 
directed mutagenesis to allow for subcloning of NLS-mCherry. The NLS-mCherry construct 
was a gift of Jon Lane. A375 cells were infected with pSL9-BAR-NLS-mCherry as 
described previously and will be referred to as A375-BAR-mCherry for brevity.13 Cells 
were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Life Technologies, 
Carlsbad, CA) with 10% fetal bovine serum (FBS, Thermo Scientific, Waltham, MA), 500 
ng / mL gentamicin sulfate and 250 ng / mL amphotericin B (Life Technologies, Carlsbad, 
CA).
Conditioned Media and Reagents
Control and Wnt-3a transfected L-cells were obtained from the ATCC and conditioned 
media was prepared according to ATCC protocol. Murine recombinant Wnt-3a was 
purchased from Sigma-Aldrich and reconstituted at 1 mg/mL in deionized (DI) water with 
0.1% bovine serum albumin and stored in aliquots at −80 °C. Aliquots were thawed and 
diluted further with phosphate buffered saline (PBS; 137 mM NaCl, 10 mM Na2HPO4, 27 
mM KCl, 1.75 mM KH2PO4, pH 7.4) and used immediately. The GSK3β inhibitor CT 
99021 (CHIR 99021, Axon Medicinal Chemistry, Vienna, VA) was stored as a 10 mM 
solution in DMSO at −20 °C.
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Cell Cloning Using Arrays of Releasable Microstructures
Single A375-NLS-mCherry cells were isolated and expanded using arrays of releasable 
microstructures as a cloning platform (detailed methods provided in supplement).26 The 
arrays were sterilized by rinsing with 70% ethanol and air-drying prior to use. A suspension 
of 4,000 A375-NLS-mCherry cells was seeded into two arrays and incubated for 16 h to 
allow the cells to adhere. After 16 h the media was exchanged and replaced with 1:1 Wnt-3a 
conditioned media and fresh DMEM and incubated for 36 h. After 36 h the arrays were 
stained with 500 ng/mL Hoechst 33342 in PBS for 15 min which was then replaced with 
fresh DMEM. The array was moved to an inverted microscope (TE-2000-U, Nikon 
Instruments Inc. Melville, NY) mounted with a custom fabricated collar to hold a 150 µm 
diameter needle (Roboz Surgical Instrument Co. Gaithersburg, MD) above the 4× objective. 
Array elements containing a single cell (as identified by the presence of a single fluorescent 
nucleus in the Hoechst channel) that exhibited strong reporter activation (nuclear 
localization of mCherry fluorescence) were dislodged from the array as described 
previously.26 The released, magnetic microstructures were collected individually with a 
permanent magnet and transferred to separate wells in a 96-well plate, each containing 100 
µL of expansion media (50% A375 conditioned media, 25% fresh DMEM and 25% FBS). 
A375 conditioned media was prepared by sterile filtering 20 mL of DMEM which had been 
overlaid on a T75 flask seeded with A375 cells at 50% confluence and aspirated after 
incubation for 48 h. Media was exchanged every 72 h until expanding colonies greater than 
1 mm in diameter were observed. The colonies were then released with 0.15% trypsin and 
transferred to a 6-well plate for further expansion in standard DMEM. After 3 weeks of total 
expansion, cells were present at sufficient density to passage and aliquots were 
cryopreserved in FBS with 10% DMSO. A total of 6 monoclonal cell lines were generated 
and maintained for characterization. Fresh aliquots of monoclonal cells were used for at 
least 1 passage after thawing and within 3 passages after thawing.
Single Cell Tracking and Reporter Dynamics Measurement
All 6 monoclonal A375-BAR-mCherry cell lines were screened on 3 cell culture substrates: 
tissue culture treated polystyrene (TC), fibronectin (Fbn) and gelatin (Gel). To prepare the 
fibronectin-coated surface, wells of a tissue culture treated 96-well plate were incubated at 
25 °C in 50 µL of 20 µg/mL of human plasma fibronectin (EMD Millipore, Billerica, MA) 
for 1 h then rinsed 3× with PBS before use. Gelatin coated wells were prepared by 
incubating at 25 °C in 0.1% gelatin in water (EMD Millipore) for 1 h, then rinsed 3× with 
PBS before use. 1000 cells from each monoclonal line were seeded into two wells each with 
identical surface treatments containing 100 µL of DMEM and incubated for 16 h to allow 
the cells to adhere and stabilize. The media was aspirated and replaced with 50 µL of 
DMEM with 1 µg/mL of recombinant Wnt-3a and 250 ng/mL of Hoechst 33342 and 
incubated at 37 °C for 2 h. In control wells, media was replaced with DMEM containing 250 
ng/mL of Hoechst 33342 and a volume of 0.1% BSA in water identical to the volume added 
in media containing Wnt-3a. After 2 h the media was aspirated, the wells rinsed gently 3× 
with warm PBS (37 °C) and replaced with 100 µL of fresh DMEM and 250 ng/mL of 
Hoechst 33342. The 96-well array was then transferred to an inverted microscope (IX-81, 
Olympus America, Center Valley, PA) enclosed in a custom fabricated black Delrin housing 
with temperature, humidity (AirTherm ATX-H, World Precision Instruments, Sarasota, FL) 
Shah et al. Page 4













and CO2 (ProCO2, BioSpherix, Lacona, NY) regulation maintained at 37 °C, 60% relative 
humidity and a 5% CO2 atmosphere. The inverted microscope was outfitted with a 
motorized XY stage (MS-2000, Applied Scientific Instrumentation, Eugene, OR), a metal 
arc lamp excitation source (Lumen 200, Prior Scientific, Rockland, MA), high speed shutter 
(Lambda 10-2, Sutter Instrument Company, Novato, CA) and cooled interline CCD camera 
(CoolSnap HQ2, Photometrics, Tucson, AZ). Multiple positions within each well were 
imaged at 10× magnification in the Hoechst and mCherry channels every 10 min for 62 h 
using the multidimensional acquisition tool in the open source microscope control software, 
Micro-Mananger.27 A reference well was seeded with beads containing a fluorescent 
standard (MultiSpeck, Life Technologies) and was also imaged every 10 min in both 
channels.
The Hoechst channel image at each position and time-point was segmented using a custom 
pipeline implemented in CellProfiler28. Briefly, background fluorescence in the image was 
estimated by grayscale morphological opening and subtracted from the original image. The 
image was then smoothed with a 6 pixel median filter to reduce over segmentation of nuclei. 
The smoothed image was then converted to a black and white image with a threshold 
determined by the two-class implementation of Otsu’s method29 and segmented nuclei were 
declumped using a watershed method based on the shape of the detected nuclei. The 
segmented images were then exported with each object labeled by a 16-bit integer number 
for tracking. A custom tracking script was implemented in MATLAB (The Mathworks Inc. 
Natick, MA) using the overlap method. Briefly, the intersection of every time-adjacent pair 
of images was calculated and nuclei in each image were assigned a shared label with the 
segmented nuclei from the previous time-point with which it shared the largest overlap. A 
second search was implemented to identify nuclei which shared no overlap with a nucleus in 
a previous time-point by searching for unmatched nuclei within a 20 µm neighborhood from 
the detected nucleus’ position. In cases where no match was found by overlap or distance 
(for example when a cell migrated from outside of the field of view), a new label was 
generated and used to track that object in subsequent frames although measurements were 
only made for cells that could be tracked uninterrupted over all time-points. The labeled 
images of cell nuclei were then dilated by 5 pixels and used to integrate fluorescence in the 
mCherry channel for each corresponding nucleus at each time-point. Images of the reference 
well containing fluorescence standard beads were segmented in both channels using an 
empirical threshold and the mean fluorescence density (object intensity / object area in 
pixels) of the beads in each channel were measured at each time-point to control for 
variations in arc lamp intensity.
Array Scan Automation
Microfabricated arrays were scanned using an automated software utility that provided a 
customized interface to the µManager microscope control libraries. Array scanning required 
four steps: user input of the array geometry (number of rows and columns, array element 
dimensions), user-assisted localization of 2 opposing or 3 adjacent array corners, user-
assisted focus at 4 or more positions in the array to calculate the plane of best fit and the 
sequential imaging of each field of view within the array. Images from each field of view 
were segmented based on the position of each microstructure which was calculated by 
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interpolating from the user-identified corner positions and images of each individual 
microstructure were saved separately for image analysis.
Clonogenic Screening
Microfabricated cell arrays (110×110 array, rows × columns, 200×200×35 µm elements, 
length × width × height) were fabricated and prepared as previously described (detailed 
methods provided in supplement).30,31 For clonogenic screening, the arrays were mounted 
in custom cassettes fabricated by 3D printing polylactic acid with a convention fusion 
deposition modeling printer (BFB-3000, Bits from Bytes Ltd, now 3D Systems Inc. Rock 
Hill, SC) by gluing with a small amount of PDMS. The mounted arrays were sterilized by 
rinsing with 75% ethanol in water and air-dried prior to coating with fibronectin. The 
fibronectin coating was prepared by incubating the arrays in 20 µg/mL fibronectin in PBS 
for 2 h at 25 °C. The arrays were then rinsed 3× with PBS and immediately seeded with 
cells.
A total of 3,000 cells from the polyclonal A375-BAR-mCherry line were seeded onto each 
of 4 arrays and incubated for 16 h. After 16 h, the media was exchanged and the cells were 
incubated in 500 ng/mL of Hoechst 33342 in DMEM for 15 min at 37 °C and rinsed 3× with 
PBS. Two arrays were overlaid with DMEM containing 1 µg/mL of recombinant Wnt-3a 
and 2 arrays were overlaid with DMEM containing 5 µM CT 99021. The arrays were 
immediately scanned at 4× magnification to measure Hoechst and basal mCherry 
fluorescence. After scanning, the arrays were incubated for 36 h at 37 °C, rinsed 3× with 
PBS and incubated in DMEM containing 500 ng/mL of Hoechst 33342 in DMEM for 15 
min at 37 °C. The arrays were again rinsed 3× with PBS and immediately scanned. After an 
additional 36 h, the arrays were re-stained with Hoechst 33342, rinsed and the media was 
replaced prior to scanning. The media was exchanged 48 h later but the arrays were not 
scanned. A total of 5 d after the previous scan and after single cells on the array had 
expanded into colonal colonies, the media was exchanged, the arrays stained with Hoechst 
33342, and overlaid with solutions of recombinant Wnt-3a and CT 99021 as described 
above and the arrays were again scanned. After 36 h, the arrays were rinsed, stained and 
overlaid with DMEM prior to the final scan. Images from scanned arrays were segmented 
using the CellProfiler pipeline described above with parameters empirically adjusted to 
account for the higher background fluorescence from the photoresist substrate and lower 
magnification of the images. The integrated mCherry fluorescence was processed in terms of 
fluorescence density (RFU / pixel) using MATLAB since the mean fluorescence density of a 
colony will not be affected by under or over-segmentation errors caused by densely 
clustered cell nuclei. The purity of monoclonal colonies was assessed by manually 
inspecting the images of 25 microstructures on each array which had at least 2 adjacent 
microstructures with no cells at the first time-point of the experiment.
Results and Discussion
Description of BAR-mCherry Reporter
Monoclonal cell lines are widely utilized in quantitative biomolecular and biophysical 
assays in an attempt to reduce biological variability as a source of noise.19–23 The generation 
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of monoclonal cell lines requires the expansion of single cells over tens of generations to 
provide a sufficiently large number of cells to process using conventional tissue culture 
techniques. The evolution of monoclonal cell lines over these timescales has not been well 
characterized. To characterize a reporter system in monoclonal cell lines, A375 cells were 
infected with a β-catenin activated reporter (BAR) driving expression of a nuclear 
localization signal-tagged mCherry red fluorescent protein (NLS-mCherry). The BAR-
mCherry reporter utilizes 12× TCF/LEF binding sites upstream of an NLS-tagged mCherry 
construct to function as a readout for Wnt/β-catenin signaling (Figure 1A). In A375-BAR-
mCherry cells, NLS-mCherry is not produced at levels detectable by fluorescence 
microscopy (Figure 1B) until treatment with Wnt3A ligand (Figure 1C). The nuclear 
localization signal leads to accumulation of mCherry in the nucleus, simplifying automated 
image analysis as only segmentation of the nucleus is required to quantify mCherry 
fluorescence.
Variability in Wnt Signaling Reporter Activity
Six monoclonal cell lines were generated from a polyclonal population of A375 cells 
transfected with BAR-mCherry for the characterization of reporter dynamics. These clones 
were expanded over multiple generations (3 weeks, >25 generations) on a conventional 
polystyrene surface to populations large enough to be passaged and manipulated 
conventionally and the dynamics of reporter activation were measured at the single cell level 
within each clone. Cells were tracked for 62 h with or without a brief treatment of 
recombinant Wnt-3a (1 µg/mL, 2 h). The production of mCherry over time was measured 
from a total of 1,895 treated cells (Figure S1) and 781 untreated cells (Figure S2) cultured 
on polystyrene by fluorescence microscopy and single-cell tracking.
Significant variability was observed in both the kinetics (Figure 2A) and magnitude (Figure 
2B) of Wnt reporter activation between A375-BAR-mCherry clones, however the magnitude 
of activation (12 pair-wise differences, p < 0.01, p-values listed in Table S1) was seen to 
vary more between clones than the kinetics of activation (6 pair-wise differences, p < 0.01, 
p-values listed in Table S2). Clone 2 was observed to be the most unique of all 6, showing 
significant differences in the median magnitude of activation and the time to reach peak 
activation relative to all other clones tested. Clones 1, 3, 5 and 6 exhibited pairwise 
differences in their median peak magnitude of activation between all but one other clone 
with similarities observed between clones 1 and 3 and clones 5 and 6. The kinetics of 
activation varied minimally in clones 2 through 6, with the only additional pair-wise 
difference existing between clones 2 and 4. The signal relaxation kinetics of single A375-
BAR-mCherry cells, while highly varied (µ = 6.5 h, σ = 5.6 h), did not exhibit many 
differences between clones (Figure 2C). Only 2 statistically significant pair-wise differences 
were observed in the median time for signal to relax to half peak fluorescence (p < 0.01, p-
values listed in Table S3); between clones 2 and 4 and clones 4 and 6. The activation 
kinetics, peak activation magnitude and signal relaxation rate of BAR-mCherry are believed 
to be a function of 3 basic processes: induction of Wnt signaling and activation of the BAR-
mCherry reporter, synthesis and nuclear transport of NLS-mCherry and the non-specific 
proteasomal degradation of NLS-mCherry. In addition to significant intraclonal variability 
in the magnitude and kinetics of reporter activation and inactivation, the interclonal 
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variability observed (primarily in peak activation magnitude and to a lesser extent in 
activation kinetics) is suggestive of the presence of fundamental differences in Wnt 
signaling, transcriptional, translational and degradation phenotypes between individual 
monoclonal cell lines.
Variations in Reporter Dynamics Are Regulated by Independent Processes
Hoechst fluorescence, a measure of DNA concentration, and reporter activation kinetics 
were not correlated with reporter activation magnitude for any individual clone (Table S4) 
or for the measurements of all clones pooled together (Figure 3A, B). The nuclear size and 
Hoechst fluorescence intensity of cells was observed to vary significantly even within 
monoclonal populations, suggestive of aneuploidy. Wnt signaling is modulated during the 
cell cycle32,33, however it is not possible to correlate progression through the cell cycle with 
DNA concentration in an aneuploid population. In comparing the mean intensity of nuclear 
Hoechst fluorescence over the course of the experiment against the peak activation 
magnitude (Figure 3A), no correlation between the two measurements was seen for any of 
the clones (r2 = 0.09). Thus the amount of DNA present in each cell did not appear to 
influence the magnitude of reporter activation and the magnitude of reporter activation was 
independent of DNA content or degree of aneuploidy. The kinetics of activation (as 
measured by the time require to reach peak fluorescence intensity) were also uncorrelated 
with the magnitude of activation (r2 = 0.15; Figure 3B). While the rate of signal 
accumulation varied significantly from cell-to-cell, it was not dependent on or influenced by 
the activation magnitude of the reporter. This suggests that the rate and magnitude of 
reporter activation were regulated by distinct processes. It is likely that the rate of signal 
accumulation was a function of the kinetics of NLS-mCherry translation and degradation 
while the magnitude of reporter activation was a function of the fold-change in the nuclear 
concentration of β-catenin.15 The signal relaxation kinetics of all 6 clones varied widely 
from cell to cell, but was observed to be uncorrelated with either peak activation magnitude 
(Figure 3C, r2 = 0.01) or the time required to reach peak activation (Figure 3D, r2 = 0.006). 
In tumor cells, non-specific proteasomal degradation likely dictates the reporter signal decay 
rate due to the critical role protein degradation plays in survival.34–36 In totality, these 
observations strongly support the interpretation that the kinetics of reporter activation, the 
magnitude of reporter activation and the kinetics of signal relaxation were independently 
regulated and highly variable processes in A375-BAR-mCherry. While we could not test for 
correlations between cell cycle and reporter activation magnitude, Hoechst fluorescence, a 
measure of DNA concentration was not correlated with reporter activation magnitude.
Matrix-dependence of Wnt/β-catenin Reporter Activation
The influence of extracellular matrix (ECM) mediated signaling on the reporter phenotype 
was also characterized for each clone as a potential indicator of inter-clonal phenotypic 
variability as integrin signaling is known to promote Wnt activity.37–40 Differential integrin 
binding to polystyrene, gelatin and fibronectin surfaces was expected to produce different 
degrees of reporter modulation in cells treated with Wnt. Three culture substrates were 
evaluated: tissue-culture polystyrene, human-plasma fibronectin, and gelatin. Cells cultured 
on each substrate were tracked for 62 h with or without a brief treatment of recombinant 
Wnt-3a (1 µg/mL, 2 h). The production of mCherry over time was measured from a total of 
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5,598 treated cells (Figure S1) and 2,647 untreated cells (Figure S2) by fluorescence 
microscopy and single-cell tracking. Reporter activation kinetics, peak activation magnitude 
and signal relaxation kinetics for cells cultured on fibronectin and gelatin were observed to 
be similarly uncorrelated as compared to cells cultured on polystyrene (Figure S3A-C). 
Reporter activation magnitude was also similarly uncorrelated with mean Hoechst 
fluorescence (Figure S3D). This further reinforces our conclusion that these components of 
overall reporter dynamics are independent of each other as well as of ECM-mediated effects 
on Wnt signaling in A375-BAR-mCherry.
While significant intraclonal heterogeneity was present in all clones on all cell culture 
substrates in terms of reporter activation kinetics (Figure 4A) and relaxation kinetics (Figure 
4C), the ECM did not possess a strong impact on these attributes in most clones. In terms of 
reporter kinetics, activation rates (Figure 4A) exhibited a dependence on cell culture 
substrate in only two clones (p < 0.01, p-values listed in Table S5), while signal relaxation 
rates (Figure 4C) exhibited no dependence on ECM interactions (p < 0.01, p-values listed in 
Table S6). Within clones 3 and 4, a statistically significant difference was observed in the 
time required to reach peak mCherry fluorescence between cells cultured on fibronectin and 
cells cultured on gelatin. Within clone 4, a difference was also observed in the time required 
to reach peak fluorescence between cells cultured on polystyrene and cells cultured on 
gelatin. The presence of only 3 statistically significant pair-wise differences out of 12 
comparisons in the dependence of reporter activation kinetics on ECM interactions 
demonstrated that that intraclonal variability in reporter activation and signal relaxation 
kinetics was generally much greater than the variability caused by ECM-dependent 
interactions.
In contrast to activation and relaxation kinetics, reporter activation magnitude was observed 
to depend on cell culture substrate (Figure 4A) with significant variations in magnitude both 
within and between clones (12 pair-wise differences out of 18 comparisons, p < 0.01, p-
values listed in Table S7). For clones 1–3, cells cultured on fibronectin reached a 
significantly higher peak fluorescence intensity (p < 0.01, p-values listed in Table S8) than 
on polystyrene or gelatin. Clones 4–6 departed from this trend, again suggesting the 
presence of distinct signaling phenotypes within the A375-BAR-mCherry population from 
which the clones were selected.
Characterization of Reporter Cell Lines by Clonogenic Screening
The dangers of phenotypic and genetic drift of in-vitro cultured cell lines over time have 
been widely discussed.41,42 In light of the time required to expand monoclonal cell lines to 
sufficient size for manipulation with conventional cell culture techniques, there is some 
question as to whether the heterogeneity observed in reporter systems for Wnt/β-catenin 
signaling are inherent to the pathway, artifacts of the reporter, a product of long-term drift or 
a combination of all three. Regardless of the origins of this diversity, there are significant 
practical implications for the use of monoclonal cell lines and transcriptional reporters. 
Studying monoclonal colonies a smaller number of generations removed from the 
originating mother cell could reduce the impact of long-term phenotypic drift and provide 
evidence as to the origins of inter- and intra-clonal heterogeneity, but would also reduce the 
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statistical power of measurements made on the smaller number of cells available. Analyzing 
a large number of monoclonal colonies in parallel would enable statistical comparisons to be 
made while also increasing the likelihood of capturing a representative sample of the diverse 
signaling phenotypes which may be present. To characterize the diversity of monoclonal 
colonies early in their evolution, we screened a large number of A375-BAR-mCherry clones 
in a massively parallel fashion using microfabcricated cell arrays.43–45 With these arrays, 
cells are prevented from migrating between adjacent microstructures by a long-lived 
intervening air bubble.31 The maintenance of clonal isolation was assessed by manually 
examining 25 microstructures and their neighboring unoccupied microstructures on each of 
4 arrays (100 microstructures in total) over 8 days. Across all 100 positions examined and 
over the 8 days, no cells ever appeared on microstructures that were unoccupied on day 1.
The clonogenic screen consisted of 3 steps: an initial activation assay on single A375-BAR-
mCherry cells after 16 h of culture on cell arrays, a 5 day expansion period in which the 
single cells grew into monoclonal colonies and a final activation assay performed on the 
monoclonal colonies at day 8 of culture (Figure 5). The activation assays were performed by 
addition of Wnt-3a or CT99021 (an inhibitor of GSK3β) to the arrayed cells followed 
imaging of Hoechst and mCherry fluorescence 36 h later. The 5-day expansion period was 
selected so that colonies could undergo up to 6 rounds of cell division (A375 doubling time 
is <20 h46). By assaying both single A375-BAR-mCherry cells and their clonal progeny, 
reporter activation of the clones could be correlated to the activity of the mother cell to track 
divergence. In addition to imaging the arrays for mCherry expression before and after the 
initial and final activation assays, a scan was performed 36 h after completion of the first 
activation assay to track signal relaxation; however, no cells were observed to be detectably 
more fluorescent than basal levels at this time-point. A total of 1,119 clones were assayed 
over four arrays. Of these, 684 clones were tracked on two arrays treated with Wnt-3a and 
435 clones were tracked on two arrays treated with CT 99021.
Evidence of Cell Division-Dependent Wnt Signaling Feedback
On average, daughter cells treated with Wnt-3a (Figure 6A) showed 13.9% lower peak 
fluorescence relative to their corresponding mother cells. Reporter activation magnitude was 
observed to vary with the number of cell divisions a colony underwent in A375-BAR-
mCherry clones treated with Wnt-3a (Figure 6A, C). Cells which were viable but remained 
non-proliferative (corresponding to 0 divisions) exhibited significantly (p < 0.01) weaker 
mCherry fluorescence during the second treatment step relative to the first treatment. Cells 
that did not divide did not exhibit detectably greater basal levels of activation prior to the 
second treatment. This observation directly supports previous evidence of the self-inhibition 
by Wnt/β-catenin pathway activation47 (Figure 1A). Multiple downstream gene targets of β-
catenin include Wnt signaling inhibitors such as DKK48, which causes Frizzled receptor 
internalization, β-transducin repeat containing protein49 (β-TrCP), which mediates 
ubiquitination of phosphorylated β-catenin, and Axin250, a key scaffold for the destruction 
complex.
Cell division or associated signaling processes regulate Wnt self-inhibition. Colonies treated 
with Wnt-3a that underwent multiple cell divisions (>2) exhibited significantly increased 
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reporter activation levels relative to the overall population (Figure 6C; p < 0.01). Cell 
density has been observed to play a role in the modulation of Wnt signaling, potentially due 
to cross-talk between the cytosolic and adherens-associated pools of β-catenin.16 This 
relationship has been observed to be inhibitory in nature as up-regulation of the formation of 
adherens-junctions may reduce the cytosolic pool of β-catenin available for Wnt-induced 
signaling.51 In contrast, we observed that smaller colonies exhibited a lower level of 
signaling activation relative to their mother cell while larger colonies exhibited an increase 
in signaling activation. This sensitization of dense clonal colonies to Wnt-induced signaling 
is likely a consequence of signaling distinct from the adherens-associated β-catenin pool, of 
which there are several potential candidates.
A number of positive feedback loops for Wnt pathway activation have been identified with 
oncogenic implications.52–55 These feedback loops regulate Wnt signal transduction at both 
the receptor and destruction complex level and can lead to increased β-catenin expression 
levels. Additional investigations will be necessary in order to identify the mechanisms 
underlying the change in colony signaling we observed. Any potential link between positive 
feedback and cell division remains even less clear, although several of the signaling 
pathways identified in the literature which feed into Wnt signaling are also tied to 
proliferative phenotypes including hepatocyte growth factor receptor56,52 (HGFR), 
extracellular signal-regulated kinases53 (ERK), c-Myk57 and phospholipase D155 (PLD1). 
We speculate that our observed correlation of increased Wnt sensntivity with clonal colonies 
undergoing multiple divisions (Figure 6C) could represent an effect of increased feedback 
activity from Wnt signaling partners rather than the cause of sensitization. At least some of 
the heterogeneity we observed can likely be attributed to epigenetic silencing or activation 
of reporter integration sites58, however epigenetic silencing of the reporter should be 
randomly distributed over a sufficiently large number of sub-clones and should not exhibit a 
bias that is dependent on the point of pathway activation or cell division.
Inhibition of GSK3β Removes Cell Division-Dependence of Reporter Activation
In A375-BAR-mCherry clones treated with CT99021, reporter activation magnitude was 
seen to decrease by an average of 8.34% relative to the activation magnitude of the mother 
cells. Reporter activation magnitude did not vary with the number of divisions a colony 
underwent (Figure 6B, D). The lack of a trend in clones treated with CT99021 (p > 0.01, 
Figure 6D) agrees with proposed mechanisms of Wnt self-inhibition as this feedback is 
integrated at or before the level of the destruction complex. Since GSK3β inhibition directly 
inhibits the function of the destruction complex, desensitization to Wnt by increased 
expression of DKK, β-TrCP or Axin2 in cells would have no effect on the induction of 
signaling in cells treated with CT 99021. Positive feedback was also not evident in colonies 
treated with CT99021 as the distribution of the fold-change in reporter activation magnitude 
was homogenous with respect to the number of cell divisions each colony underwent (Figure 
6D). Since the known mechanisms of Wnt sensitization and positive feedback also function 
at or upstream of the destruction complex, their effects on reporter activation by treatment 
with CT 99021 would be expected to have been significantly reduced. While increased β-
catenin expression levels might still result in positive feedback, recent evidence suggests 
that Wnt signaling is defined by a fold-change in nuclear β-catenin concentration, not the 
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absolute concentration and the magnitude of reporter activation we observed was likely 
dominated by the activity of CT 99021.15
Conclusions
Our observations present a cautionary tale regarding the reliance on monoclonal cell lines as 
reporter systems for the study of intracellular signaling. Conventional in-vitro reporter-based 
assays probe simplified systems in which the dynamics of cellular signaling and interactions 
are suppressed or reduced through strategies such as the generation of monoclonal cell lines, 
however this is fraught with risk. We observed the selection of distinct signaling phenotypes 
in the generation of monoclonal cell lines which may represent (or miss) rare subpopulations 
in the polyclonal population or which may not exist in-vivo. In the characterization of ECM-
dependent modulation of reporter activation, we observed significant differences in the 
pattern of signal enhancement and inhibition between clones. As extracellular signaling is 
integrated into Wnt signaling through multiple intermediates37–40, it is possible that these 
distinct phenotypes may be defined by differences in expression levels or mutations in 
intermediate signaling cascades or receptor signaling complexes. This is an alarming 
observation for signaling investigations which rely on monoclonal cell lines as 
characterization of individual clones with different signaling phenotypes could lead to 
seemingly contradictory observations. For example, selection of a single clone could provide 
evidence that fibronectin-mediated integrin signaling enhances Wnt-induced reporter 
activation (eg. clone 1) or, if a different clone had been selected, the same experiments could 
suggest the opposite relationship (eg. clone 5). The use of single monoclonal cell lines 
should thus be avoided in the study of signaling pathways as phenotypes and interactions 
identified may vary significantly between different clones, even those prepared from the 
same cell line, reducing the generalizability of findings and making their replication 
challenging. We observed reporter activation levels diverge within 5 generations of the 
isolation of clonal populations over a 2-log range (0.1–10× the relative signal response of 
the mother cells). This range matches closely with observations in a different biological and 
reporter system for β-catenin5, suggesting that our observations are not unique to A375-
BAR-mCherry. Single-cell resolution measurements of polyclonal populations are likely a 
more robust platform for screening and discovery. Combining single-cell measurements 
with a platform for performing cell isolations, such as arrays of releasable microstructures, 
would allow sub-populations exhibiting distinct phenotypes to be separated and further 
studied. This would enable a more robust and complete characterization of heterogeneous 
samples without bias towards specific phenotypes which may be present.
Our observations strongly support the existence of both positive and negative feedback in 
Wnt/β-catenin signal activation, at least in the A375 cell line. While further study will be 
necessary to identify the mechanisms underlying the changing signaling phenotypes that we 
observed, the correlation of Wnt sensitivity with different colony sizes suggests that cell 
division or a combination of associated molecular signaling events may play a role in 
modulating both the negative and positive self-regulation of Wnt signaling. To perform a 
clonogenic screen on the scale that was presented here by limiting dilution would require an 
average of 3,042 wells to be seeded, consuming eight 384-well plates, 245.8 mL of media 
per exchange and 245.8 µg of Wnt-3a. Cell array technology enables the rapid performance 
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of a massively parallel clonogenic screen with comparatively little reagent consumption; in 
ideal cases up to a 99.5% reduction in reagent consumption on a per-clone basis relative to 
well-plate screening (Table S9). Additionally, the ability to sort individual selected clones 
can be utilized in future studies to trace the mechanisms of emergent heterogeneity as well 
as in the identification of novel regulators of Wnt signaling.
Our observation of multiple clones with diverse signaling phenotypes within a single cell 
line (Figure 2A & B) highlights the risks of artificially reducing diversity within a reference 
population, particularly for tumor cells which are known to host diverse subpopulations.6,7 
High throughput screens20,21,59, fundamental investigations of intracellular signaling60,61 
and single-cell measurements8,19 performed using a small number of clones could be 
dramatically affected by the unintentional selection of distinct phenotypes and their results 
may prove difficult to reproduce or contradictory to the investigations of other groups as a 
consequence, despite their accuracy within their respective reference systems.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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This work integrates microfabricated cell arrays with automated imaging cytometry and 
image analysis to generate insight into the evolution of transcriptional reporters. 
Automated imaging of microfabricated cell arrays enabled massively parallel screening 
and robust tracking of >1,000 clonal cell colonies to observe emergent signaling 
phenotypes and heterogeneity. These observations provide insight into Wnt-3a signaling 
dynamics and highlight challenges facing the use of monoclonal cell lines as reporter 
systems in cell signaling assays and high throughput screening.
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(A) Simplified schematic of BAR-mCherry integration into the canonical Wnt/β-catenin 
signaling cascade. (i) Wnt-3a binding to Frizzled results in inhibition of the destruction 
complex. (ii) β-catenin translocated to the nucleus drives gene expression in concert with 
TCF/LEF transcription factors. (iii) BAR-mCherry is produced from active β-catenin 
signaling and builds up as long as production exceeds degradation. (iv) Downstream targets 
of Wnt include several of its own regulators including Axin and β-TrCP which mediate β-
catenin degradation and DKK which causes Frizzled receptor internalization. Example 
images showing A375-BAR-mCherry cells treated with L-cell conditioned media (no 
Wnt-3a) (B) and Wnt-3a conditioned media (C) for 24 h. Nuclei are counterstained with 
Hoechst 33342 (blue) to show nuclear localization of NLS-mCherry (red, merge = pink). 
Scale bar is 100 µm.
Shah et al. Page 17














Box and whisker plots showing the distribution of (A) times required to reach peak 
fluorescence, (B) the peak mCherry fluorescence achieved and (C) the time required for 
signal to decay to half peak fluorescence for single A375-BAR-mCherry cells cultured on 
polystyrene. Red circles mark the population mean for each distribution. Outliers shown are 
observations above the 5th and below the 95th percentile. The boxes mark the 25th, 50th 
(median) and 75th percentiles within the distribution while the whiskers mark the 5th and 
95th percentiles.
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Comparisons between measured parameters from single-cell tracking of A375-BAR-
mCherry cells (all 6 clones are shown pooled together) cultured on polystyrene after 
treatment with Wnt3a. (A) Peak mCherry fluorescence achieved versus the mean Hoechst 
fluorescence over the 62 h time-course (r2 = 0.09) (B) Peak mCherry fluorescence versus the 
time required to reach peak fluorescence (r2 = 0.15) (C) Peak mCherry fluorescence 
achieved versus the time required for signal to decay to half peak fluorescence (r2 = 0.01) 
(D) The time required for signal to decay to half peak fluorescence versus the time required 
for cells to reach peak fluorescence (r2 = 0.006).
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Box and whisker plots showing the distributions of (A) the times to reach peak mCherry 
fluorescence, (B) the peak mCherry fluorescence intensity achieved and (C) the time 
required for signal to decay to half peak mCherry fluorescence for single A375-BAR-
mCherry cells cultured on polystyrene (clear boxes), fibronectin (dark gray boxes) and 
gelatin (diagonal striped boxes). Red circles mark the population mean for each distribution. 
Outliers shown are observations above the 5th and below the 95th percentile. The boxes 
mark the 25th, 50th (median) and 75th percentiles within the distribution while the whiskers 
mark the 5th and 95th percentiles.
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Process flow for the parallel clonogenic screen on the arrays. The experiment begins by 
seeding a single cell suspension of A375-BAR-mCherry cells onto the arrays. After 16 h the 
arrays are scanned to measure basal mCherry expression and then treated with either Wnt-3a 
or CT 99021. 36 h after treatment, the array is washed and scanned again to measure peak 
mCherry fluorescence activation. After an additional 36 h, the array is again scanned to 
track the relaxation of the mCherry signal. 84 h following the relaxation scan, the array is 
again scanned to confirm that the cells have reached basal activation levels and treated again 
with Wnt-3a or CT 99021. 36 h post-treatment, the arrays are washed and scanned again to 
measure peak mCherry fluorescence. Shown below the process flow is a series of images 
taken of a single clone over the course of the experiment. Hoechst 33342 and mCherry 
fluorescence is shown in blue and red, respectively.
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Distribution of the mean fold change in fluorescence density (RFU / pixel) between each 
clonal colony in the final time point and its corresponding mother cell for arrays treated with 
(A) Wnt-3a and (B) CT 99021. The bar color marks the nearest whole number of divisions 
each clonal colony underwent. Bar charts showing the mean fold-change for cells in each 
corresponding number of divisions for cells treated with (C) Wnt-3a and (D) CT 99021. 
Error bars show the standard error of the mean. Red line marks the total population mean. 
Asterisks mark populations found to be significantly different from the population mean (p < 
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0.01). Bars are not shown for colonies with >4 divisions due to an insufficient number of 
colonies greater than that size.
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